FGA Praises the Bipartisan Reintroduction of the Promising Pathway Act
- BY FGA
Naples, FL – This week, Senator Mike Braun (R-IN) reintroduced the Promising Pathway Act (PPA). The PPA is a bipartisan, commonsense reform that would provide early access to potentially lifesaving or beneficial treatments, biologics, or drugs to those suffering from rapidly progressing life-threatening or terminal illnesses.
Under the PPA, patients and their families who don’t have the luxury of time can receive prompt access to safe, promising treatments as soon as possible—without the FDA’s usual red tape that could make them wait 10 to 12 years for new options. Under the PPA, patients could have access to promising treatments in months, not years.
“We thank Senator Braun and the bipartisan group of cosponsors for their efforts to compassionately remove red tape for those with rapidly progressing terminal illnesses,” said Robin Walker, senior federal affairs director for the Foundation for Government Accountability (FGA). “The Promising Pathway Act is a sensible way to give patients and their families access to additional treatments, innovative drugs or biologics, and hope for the future. There’s a compelling and demonstrated need for expedited access to treatments and allowing this through the PPA is the right thing to do.”
For more FGA research and resources, visit our Advancing the Promising Pathway Act page.
###
The Foundation for Government Accountability (FGA) is a non-profit, multi-state think tank that promotes public policy solutions to create opportunities for every American to experience the American Dream. To learn more, visit TheFGA.org.
